FI864293A0 - Neovaskularisationsinhibitorer och deras framstaellnings- och anvaendningsfoerfaranden. - Google Patents

Neovaskularisationsinhibitorer och deras framstaellnings- och anvaendningsfoerfaranden.

Info

Publication number
FI864293A0
FI864293A0 FI864293A FI864293A FI864293A0 FI 864293 A0 FI864293 A0 FI 864293A0 FI 864293 A FI864293 A FI 864293A FI 864293 A FI864293 A FI 864293A FI 864293 A0 FI864293 A0 FI 864293A0
Authority
FI
Finland
Prior art keywords
och
neovaskularisationsinhibitorer
framstaellnings
anvaendningsfoerfaranden
deras
Prior art date
Application number
FI864293A
Other languages
English (en)
Other versions
FI864293A (fi
Inventor
Bert M Glaser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of FI864293A0 publication Critical patent/FI864293A0/fi
Publication of FI864293A publication Critical patent/FI864293A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/849—Eyes; vessels; umbilical cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI864293A 1985-02-26 1986-10-23 Neovaskularisationsinhibitorer och deras framstaellnings- och anvaendningsfoerfaranden. FI864293A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70625985A 1985-02-26 1985-02-26
PCT/US1986/000312 WO1986004783A1 (en) 1985-02-26 1986-02-14 Neovascularization inhibitors and methods for their production and use

Publications (2)

Publication Number Publication Date
FI864293A0 true FI864293A0 (fi) 1986-10-23
FI864293A FI864293A (fi) 1986-10-23

Family

ID=24836851

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864293A FI864293A (fi) 1985-02-26 1986-10-23 Neovaskularisationsinhibitorer och deras framstaellnings- och anvaendningsfoerfaranden.

Country Status (12)

Country Link
US (1) US4996159A (fi)
EP (1) EP0213180B1 (fi)
JP (1) JPS61246132A (fi)
AT (1) ATE81254T1 (fi)
AU (1) AU590872B2 (fi)
DE (1) DE3686927T2 (fi)
DK (1) DK509286D0 (fi)
FI (1) FI864293A (fi)
NO (1) NO864254L (fi)
NZ (1) NZ215195A (fi)
WO (1) WO1986004783A1 (fi)
ZA (1) ZA861403B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329123C (en) * 1987-10-13 1994-05-03 Moses Judah Folkman Inhibitor of angiogenesis
JPH04178328A (ja) * 1990-11-08 1992-06-25 Unitika Ltd 血管新生阻害剤
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
EP0676935B1 (en) * 1992-04-01 2001-11-07 BAXTER INTERNATIONAL INC. (a Delaware corporation) Angiogenic tissue implant systems
US5840686A (en) * 1992-09-24 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use
US6319687B1 (en) 1992-09-24 2001-11-20 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US5985330A (en) * 1996-08-05 1999-11-16 Coastside Bio Resources Inhibition of angiogenesis by sea cucumber fractions
US6350467B1 (en) 1996-12-31 2002-02-26 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
US7105496B2 (en) * 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
AU741886B2 (en) 1997-07-23 2001-12-13 Northwestern University Methods and compositions for inhibiting angiogenesis
US6797691B1 (en) * 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
US7828827B2 (en) * 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US6875165B2 (en) * 2001-02-22 2005-04-05 Retinalabs, Inc. Method of radiation delivery to the eye
US7070554B2 (en) 2003-01-15 2006-07-04 Theragenics Corporation Brachytherapy devices and methods of using them
US7563222B2 (en) 2004-02-12 2009-07-21 Neovista, Inc. Methods and apparatus for intraocular brachytherapy
CN101005873B (zh) * 2004-02-12 2010-07-21 内奥维斯塔公司 用于眼内近程治疗的设备
EP1951372A4 (en) * 2005-11-15 2011-06-22 Neovista Inc METHOD AND DEVICE FOR INTRA-ECULAR BRACHYTHERAPY
WO2008091602A2 (en) * 2007-01-22 2008-07-31 Corium International, Inc. Applicators for microneedle arrays
AU2008241470B2 (en) 2007-04-16 2013-11-07 Corium Pharma Solutions, Inc. Solvent-cast microneedle arrays containing active
WO2009048607A1 (en) * 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
JP2011522603A (ja) 2008-06-04 2011-08-04 ネオビスタ、インコーポレイテッド 放射線源ワイヤを前進させるための手持ち放射線送達システム
JP5820805B2 (ja) * 2009-04-24 2015-11-24 コリウム インターナショナル， インコーポレイテッド マイクロプロジェクションのアレイの製造のためのプロセス
AU2011248108B2 (en) 2010-05-04 2016-05-26 Corium Pharma Solutions, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
KR102265808B1 (ko) 2012-12-21 2021-06-16 코리움, 인크. 치료제의 전달을 위한 마이크로어레이 및 그것의 사용방법
JP6487899B2 (ja) 2013-03-12 2019-03-20 コリウム インターナショナル， インコーポレイテッド 微小突起アプリケータ
EP4194028A1 (en) 2013-03-15 2023-06-14 Corium Pharma Solutions, Inc. Multiple impact microprojection applicators
AU2014233541B2 (en) 2013-03-15 2018-11-22 Corium Pharma Solutions, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
MX2015012933A (es) 2013-03-15 2016-09-19 Corium Int Inc Micrordenamiento para suministro de agente terapeutico y metodos de uso.
JP2016514133A (ja) 2013-03-15 2016-05-19 コリウム インターナショナル， インコーポレイテッド ポリマーを含まない微細構造物を含むマイクロアレイ、製造方法および使用方法
EP3188714A1 (en) 2014-09-04 2017-07-12 Corium International, Inc. Microstructure array, methods of making, and methods of use
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30239A (en) * 1860-10-02 Improvement in machines for stem m ing corn-husks
USRE30239E (en) * 1975-11-10 1980-03-25 Cell proliferation and tissue invasion inhibitor
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4182753A (en) * 1978-03-29 1980-01-08 Saltarelli Cora G Sarcoma 180 tumor inhibitor and method of making same
US4176177A (en) * 1978-11-16 1979-11-27 Rush-Presbyterian-St. Luke's Medical Center Inhibition of bone resorption
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4534967A (en) * 1982-08-03 1985-08-13 Boston Biomedical Research Institute Cell proliferation inhibitor and method of preparation

Also Published As

Publication number Publication date
EP0213180B1 (en) 1992-10-07
ATE81254T1 (de) 1992-10-15
DE3686927T2 (de) 1993-03-25
NO864254L (no) 1986-10-23
DK509286A (da) 1986-10-24
AU5455386A (en) 1986-09-10
EP0213180A1 (en) 1987-03-11
DE3686927D1 (de) 1992-11-12
FI864293A (fi) 1986-10-23
AU590872B2 (en) 1989-11-23
EP0213180A4 (en) 1988-12-28
WO1986004783A1 (en) 1986-08-28
DK509286D0 (da) 1986-10-24
ZA861403B (en) 1986-12-30
JPS61246132A (ja) 1986-11-01
US4996159A (en) 1991-02-26
NZ215195A (en) 1991-11-26

Similar Documents

Publication Publication Date Title
FI864293A0 (fi) Neovaskularisationsinhibitorer och deras framstaellnings- och anvaendningsfoerfaranden.
NO820090L (no) Fremgangsmaate for fremstilling og behandling av renninderivater
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
PT76546A (en) Process for preparing functional human urokinase protein
DE3268915D1 (en) Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
NO910444D0 (no) Alkoksy-4(1h)-pyridonderivater, fremgangsmaater for fremstilling derav og deres anvendelse som legemiddel.
AU2742892A (en) An anticoagulant substance obtained from urine
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
HUT40695A (en) Dna sequences, recombinant dna molecules and processes for preparing humane lipocortine like polypeptides
ITRM970238A0 (it) Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella terapia di patologie corneali e congiuntivali
FI893795A (fi) Nya furyltiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandingar.
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
ES8200886A1 (es) Procedimiento para la preparacion de derivados del amino-1 propanol-2
ATE91626T1 (de) Pyridin- oder pyridazinderivate als kardioprotektiva und zur behandlung von ischaemischen beschwerden und herstellungsprozess.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: THE JOHNS HOPKINS UNIVERSITY